The Yoon Suk-yeol administration held its first meeting of the Central Disaster and Safety Countermeasures Headquarters (CDSCH) without “a control tower” on Wednesday, causing experts to raise concerns about its Covid-19 responses.Noticeable for their absence were the new prime minister as the head
BMS Korea said that the Ministry of Food and Drug Safety has recently approved its myelofibrosis treatment Inrebic (ingredient: pedratinib) and myelodysplastic syndrome treatment Reblozyl (ingredient: ruspartercept),Inrebic received approval from regulators to treat adults with an enlarged spleen an
Roche Korea is strengthening its position in the local hepatocellular carcinoma market after receiving reimbursement for combination therapy of Tecentriq and Avastin as a first-line treatment, according to an expert Wednesday.“Tecentriq and Avastin combination therapy will bring major changes in tre
GC Cell said that it has signed a contract development and manufacturing organization (CDMO) agreement with Cellab Med to produce the latter's investigational drug for a solid cancer chimeric antigen receptor (CAR)-T treatment.GC Cell noted that this is the first development and manufacturing contra
Korean biotech companies said they would gather at Bio Korea 2022, a health and pharmaceutical industry trade fair, to discuss business strategies in the post-Covid-19 era.The Korea Health Industry Development Institute (KHIDI) and North Chungcheong Province jointly organized the annual event, which
HK inno.N has signed a contract with Dr. Reddy's Laboratories, an India-based multinational pharmaceutical company, to export finished products of K-CAB (ingredient: tegoprazan), a drug for gastroesophageal reflux disease (GERD), to seven countries.The seven countries are India, South Africa, Russia
The government has urgently approved the import of about 130,000 bottles of Tylenol Suspension from Australia to relieve the short local supply amid the pandemic.However, the nation has already passed the point of the extreme shortage of cold medicines in March and the government’s move is too late,
A new drug, which proved heart and kidney protection effects in chronic kidney disease (CKD) patients accompanying type-2 diabetes, has arrived in Korea to counter well-established SGLT-2 inhibitors.On Tuesday, the Ministry of Food and Drug Safety authorized the use of Bayer’s Kerendia (ingredient:
Despite ongoing slowdowns in the decline of new cases or even sporadic increases, Korea’s Covid-19 spread has been on a decreasing trend recently, albeit with one exception – the under-18 group.According to Central Disaster and Safety Countermeasures Headquarters (CDSCH) on Tuesday, the number of co
Myongji Hospital's Sports Medicine Center said that it would hold the third Myongji Hospital Sports Medicine Symposium on Sunday. The hospital will hold the symposium online through YouTube, and only those who have registered in advance can participate.Under the theme of "History, Present and Future
LegoChem Bioscience said that it would start the operation of AntibodyChem Biosciences (ACB), its U.S. subsidiary in Boston.The company established ACB to develop global new drugs based on its antibody-drug conjugate (ADC) platform technology. ACB will lead global clinical development by joining the
Lilly’s Olumiant (baricitinib) and Abbvie’s Rinvoq (upadacitinib) got health insurance benefits starting from May 1 to treat severe atopic dermatitis.Patients who used the two drugs to treat severe atopic dermatitis without health insurance will be able to get insurance benefits as long as they meet
People’s interest in decentralized clinical trials (DCTs) grew due to the Covid-19 pandemic as patients found it difficult to visit clinical trial sites.However, a government report showed that Korea still ranked low in the proportion of DCTs out of all clinical trials.Korea National Enterprise for
Ferring’s Rekovelle (follitropin delta), a treatment to promote egg production in ovaries, became reimbursable when used in combination with human menopausal gonadotropin (hMG) in women receiving in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).Ferring Korea said Rekovelle got
Celltrion Healthcare said that it would expand direct sales, previously limited to only some products, to all products in the European market.The company has sold Remsima (ingredient: infliximab), a biosimilar for treating autoimmune diseases, directly in Europe since 2019. Since then, despite inten
Hanmi Pharmaceutical said that Aptose Biosciences, its American partner, has received orphan drug designation (ODD) for HM43239, an acute myeloid leukemia (AML) treatment, from the U.S. Food and Drug Administration.The company had licensed out the treatment to Aptose in November.Under the deal, Hanm
BMS’ anemia treatment Reblozyl (ingredient: luspatercept) arrived in the Korean market only two and a half years after the company completed drug development in the U.S.The Ministry of Food and Drug Safety authorized Reblozyl to treat adult anemia patients who failed an erythropoiesis-stimulating ag
Although the decline of new Covid-19 cases stagnated over the weekend, quarantine officials predicted on Monday that there would be no sudden increase for the time being."The decline in the Covid-19 prevalence is slowing down," said Son Young-rae, head of the social strategy team in the Central Disa
The government should raise the status of the Korea Disease Control and Prevention Agency (KDCA) to the tentatively titled “Ministry of Health” to integrate the management and operation of the public health system.The Korea Institute of Public Administration, a government-financed research organizat
Korea Atomic Energy Research Institute (KAERI) said that it has exported Germanium-68, a medical radioactive isotope, to Sanders Medical, a U.S. medical device company.According to the state-invested institute, the contract with Sanders Medical marks the first time that Korea has exported a radioact